Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.30 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1803635 | 0.93 | CHRM2 (0.43) | CHRM2CHRM1ALDH1A1MAPTMAPK1 | |
| SCHEMBL28615816 | 0.89 | TP53 (0.36) | CHRM2CHRM1ALDH1A1MAPTMAPK1 | |
| SCHEMBL25625929 | 0.87 | DAO (0.41) | CHRM2CHRM1ALDH1A1MAPTMAPK1 | |
| SCHEMBL6248417 | 0.87 | ALDH1A1 (0.38) | ALDH1A1KMT2ASMN1; SMN2 | |
| Isopropyl Alcohol SCHEMBL7567318 | 0.85 | KMT2A (0.41) | CHRM2CHRM1ALDH1A1MAPTHTT | |
| SCHEMBL1662667 | 0.84 | CHRM2 (0.34) | CHRM2CHRM1ALDH1A1MAPTMAPK1 | |
| SCHEMBL1061900 | 0.84 | CHRM2 (0.34) | CHRM2CHRM1ALDH1A1MAPTMAPK1 | |
| SCHEMBL27955546 | 0.83 | CHRM2 (0.36) | CHRM2CHRM1ALDH1A1HTTKMT2A | |
| SCHEMBL27831166 | 0.82 | CHRM2 (0.45) | CHRM2CHRM1ALDH1A1MAPTHTT | |
| Water SCHEMBL15641760 | 0.82 | PTGS1 (0.36) | ALDH1A1MAPTMAPK1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105754956-B | Sample pretreatment liquid for detecting and separating respiratory viruses of sample | 上海市浦东新区疾病预防控制中心 | 2020-05-26 | — | — | CN | claimed |
| US-9428730-B2 | Coatings and culture media for promoting neurogenesis in adipose tissue derived stem cells | MEAD JOHNSON NUTRITION COMPANY (US) | 2016-08-30 | — | — | US | claimed |
| US-20240197898-A1 | SUBSTITUTED BENZO[5,6][1,4]DIAZEPINO[1,2-a]INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | IMMUNOGEN, INC. | 2024-06-20 | — | — | US | disclosed |
| CN-118032958-A | HPLC quantitative detection method of chondroitin sulfate based on GalN-AQC derivatization | 中国检验检疫科学研究院 | 2024-05-14 | — | — | CN | disclosed |
| US-11793885-B2 | Substituted benzo[5,6][1,4]diazepino[1,2-a]indoles for the treatment of proliferative disorders | IMMUNOGEN, INC. (US) | 2023-10-24 | — | — | US | disclosed |
| CN-110267685-B | ADAM 9-targeting immunoconjugates and methods of use thereof | 伊缪诺金公司 | 2023-06-20 | — | — | CN | disclosed |
| US-11530295-B2 | Hydrophilic polymer derivative having cyclic benzylidene acetal linker | NOF CORPORATION (JP) | 2022-12-20 | — | — | US | disclosed |
| US-11529423-B2 | Biodegradable polyethylene glycol derivative having cyclic benzylidene acetal linker | NOF CORPORATION (JP) | 2022-12-20 | — | — | US | disclosed |
| CN-110156880-B | Zika virus vaccine composition and application thereof | 吴夙钦 | 2022-12-16 | — | — | CN | disclosed |
| CN-113117016-B | Application of polygonatum kingianum extract in preparation of composition for promoting testosterone generation | 百岳特生物技术（上海）有限公司 | 2022-11-04 | — | — | CN | disclosed |
| EP-3210623-B1 | ANTIBODY-DRUG COMPLEX HAVING CYCLIC BENZYLIDENE ACETAL LINKER | NOF CORP (JP) | 2022-10-05 | — | — | EP | disclosed |
| US-20060286017-A1 | Waste gas treatment process including removal of mercury | CANSOLV TECHNOLOGIES INC. (CA) | 2006-12-21 | — | — | US | disclosed |
| US-20060021506-A1 | Method and apparatus for NOx and Hg removal | CANSOLV TECHNOLOGIES INC. (CA) | 2006-02-02 | — | — | US | disclosed |
| WO-2006010262-A1 | METHOD AND APPARATUS FOR NOX AND Hg REMOVAL | CANSOLV TECHNOLOGIES INC. (CA) | 2006-02-02 | — | — | WO | disclosed |
| US-20040022790-A1 | CNS neurite outgrowth modulators, and compositions, cells and methods embodying and using same | SCHACHNER, MELITTA (DE) | 2004-02-05 | — | — | US | disclosed |
| US-6576607-B1 | Administering neural cell adhesion molecule which overcomes inhibitory molecular cues found on glial cells and myelin | ACORDA THERAPEUTICS | 2003-06-10 | — | — | US | disclosed |
| US-5801149-A | PEPTIDS FOR INHIBITION OF PROTEINS | JOSLIN D-ABETES CENTER, INC. (US) | 1998-09-01 | — | — | US | disclosed |
| US-5792743-A | TREATMENT OF CENTRAL NERVOUS SYSTEM OR BRAIN DISORDERS WITH GROWTH STIMULANT, E.G. L1 WHICH COMPRISES IMMUNOGLOBULIN-LIKE DOMAINS AND FIBRONECTIN TYPE III HOMOLOGOUS REPEATS; MEMORY ENHANCEMENT, ALZHEIMER'S DISEASE | ACORDA THERAPEUTICS (US) | 1998-08-11 | — | — | US | disclosed |
| US-4812384-A | Light-sensitive polycondensation product containing diazonium groups, process for the preparation thereof, and light-sensitive recording material containing this polycondensation product | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-03-14 | — | — | US | disclosed |
| US-4711847-A | Preparation of secretin | 501 Hoechst Aktiengesellschaft (DE) | 1987-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11529423-B2 | Biodegradable polyethylene glycol derivative having cyclic benzylidene acetal linker | AMDHD2, PGD, TREH | CHRM2 4494/4885CHRM1 4579/4885ALDH1A1 405/4885 |
| US-20240197898-A1 | SUBSTITUTED BENZO[5,6][1,4]DIAZEPINO[1,2-a]INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | MKI67, GABBR1, GABBR2 | CHRM2 1616/4885CHRM1 1219/4885ALDH1A1 540/4885 |
| US-11530295-B2 | Hydrophilic polymer derivative having cyclic benzylidene acetal linker | H1-2, H1-0, H1-3 | CHRM2 1185/4885CHRM1 368/4885ALDH1A1 894/4885 |
| US-11793885-B2 | Substituted benzo[5,6][1,4]diazepino[1,2-a]indoles for the treatment of proliferative disorders | MKI67, GABBR1, GABBR2 | CHRM2 1616/4885CHRM1 1219/4885ALDH1A1 540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.